We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Sorafenib in Urothelium Cancer of Bladder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01215266
Recruitment Status : Terminated (Slow recruitment)
First Posted : October 6, 2010
Last Update Posted : September 8, 2011
University Hospital, Essen
Information provided by (Responsible Party):
Association of Urologic Oncology (AUO)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2011
  Study Completion Date : June 2011